| URL | https://www.contractpharma.com/contents/view_break |
| Source | Contract Pharma |
| Date Published | 04/13/2023 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | VintaBio |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2023 |
| Capital investment ($): | 64 |
| City reshored to: | Philadelphia |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | viral vectors, cell, gene therapy |